- Home
- LNTH vs AG Comparison
LNTH vs AG Comparison
Compare LNTH & AG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LNTH | AG |
|---|---|---|
| Founded | 1956 | 1979 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 5.9B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | LNTH | AG |
|---|---|---|
| Price | $63.42 | $15.01 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $74.17 | $14.25 |
| AVG Volume (30 Days) | 1.1M | ★ 16.1M |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 0.13% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.39 | 0.16 |
| Revenue | ★ $1,525,933,000.00 | $965,571,000.00 |
| Revenue This Year | $0.01 | $107.63 |
| Revenue Next Year | $1.24 | $18.81 |
| P/E Ratio | ★ $26.45 | $108.04 |
| Revenue Growth | 1.95 | ★ 83.84 |
| 52 Week Low | $47.25 | $5.09 |
| 52 Week High | $111.29 | $16.28 |
Technical Indicators
Market Signals| Indicator | LNTH | AG |
|---|---|---|
| Relative Strength Index (RSI) | 71.16 | 64.62 |
| Support Level | $57.44 | $14.84 |
| Resistance Level | $59.30 | $16.28 |
| Average True Range (ATR) | 2.14 | 0.83 |
| MACD | 0.82 | 0.36 |
| Stochastic Oscillator | 91.35 | 78.15 |
Price Performance
Historical ComparisonAbout LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About AG First Majestic Silver Corp. (Canada)
First Majestic Silver Corp is engaged in the production, development, exploration, and acquisition of mineral properties with a focus on silver and gold production in North America. It owns three producing mines in Mexico consisting of the San Dimas Silver/Gold Mine, the Santa Elena Silver/Gold Mine, and the La Encantada Silver Mine.